BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth quarter ended December 31, 2020 . The Company also announced its current cash position of approximately $25 million , providing it with the resources to execute its revenue growth strate
January 26, 2021
· 4 min read